Albemarle (ALB) reported Q3 EPS of $7.50, $0.72 better than the analyst estimate of $6.78. Revenue for the quarter came in at $2.1 billion versus the consensus estimate of $2.2 billion.
GUIDANCE:
Albemarle sees FY2022 EPS of $19.75-$21.75, versus the consensus of $21.28. Albemarle sees FY2022 revenue of $7.1-7.4 billion, versus the consensus of $7.51 billion.